Clinical Trial Update: Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating cadonilimab with gemcitabine/cisplatin as first-line therapy for advanced intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Cadonilimab
• Gem/Cis

Snippet

Sponsor: Shen Feng | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: UNKNOWN